Leoclan Co Ltd
TSE:7681
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (0), the stock would be worth ¥22.27 (97% downside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.4 | ¥840 |
0%
|
| 3-Year Average | 0 | ¥22.27 |
-97%
|
| Industry Average | 1.5 | ¥2 930.44 |
+249%
|
| Country Average | 1 | ¥1 838.15 |
+119%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Leoclan Co Ltd
TSE:7681
|
5B JPY | 0.4 | 21 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
100.1B USD | 5 | 23.1 | |
| US |
|
Cencora Inc
NYSE:COR
|
59.1B USD | 3.2 | 36.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
59.5B USD | 3.2 | 36.6 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
46.1B USD | 3.2 | 27.7 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.3B AUD | 4.8 | 35.5 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.4B CNY | 0.6 | 11.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.6B USD | 1.2 | 21.5 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.5B CNY | 2.1 | 20.6 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 4.7 | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
57.6B HKD | 0 | 7.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.7 |
| Median | 1 |
| 70th Percentile | 1.5 |
| Max | 23 050 349 |
Other Multiples
Leoclan Co Ltd
Glance View
Leoclan Co. Ltd. engages in the wholesale and repair of medical equipment and devices. The company is headquartered in Settsu-Shi, Osaka-Fu and currently employs 162 full-time employees. The company went IPO on 2019-10-02. The firm operates in three business segments. The Medical Total Solution segment is engaged in the contract sale of medical equipment and medical information system products based on consulting for medical institutions, prevention and examination facilities, nursing care and welfare facilities, as well as the related maintenance services business, the building interior work and medical equipment construction business. The Remote Image Diagnosis Service segment is engaged in the provision of remote diagnosis services through image data taken by magnetic resonance imaging (MRI) and computed tomography (CT) for medical institutions without a radiation diagnosis specialist. The Provide Lunch segment is engaged in the provision of ordinary and recuperation meal services for nursing and welfare facilities.
